Atlas Trials

Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the Treatment of Adult Upper Limb Spasticity .

Clinical trial NCT07242300 · RECRUITING

Trial details

NCT number
NCT07242300
Sponsor
JHM BioPharma (Tonghua) Co. , Ltd.
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Upper Limb Spasticity (ULS)
Start date
2025-12-11
Primary completion
2026-12-01
Enrollment
207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.